Abstract:Objective To investigate the anti-chronic stress effect of bone marrow mesenchymal stem cell (BMSCs) transplantation in rats with spinal cord injury.Methods Forty-eight adult SD rats were divided into control group,model group and treatment group according to the random number table,with 16 rats each.In model and treatment groups,lower thoracic (T10) spinal cord injury were constructed using the modified Allen's method.In control group,only laminectomy was performed.After 7 days,100 μl Hank's buffer suspension containing 1.0 × 106 BMSCs was injected into the subarachnoid space of L4-5 intervertebral space of rats in control group and treatment group.While in model group,only the equal volume of Hank's buffer was used.Basso-Beattie-Bresnahan (BBB) scale was performed to evaluate hindlimb motor function in rats.At postoperative 14 and 28 days,blood samples were collected to measure adrenocorticotropic hormone (ACTH),norepinephrine (NE),epinephrine (E) and corticosterone (CORT) using the ELISA method;brains were harvested for the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor proteins GluR1 and GluR2 immunohistochemical staining.Results After injury,BBB scores in model and treatment groups were similar,but both were lower than that in control group (P ＜ 0.05).After BMSCs transplantation,BBB score in treatment group [21 d:(9.85 ± 0.82)points and 28 d:(11.23 ±0.68)points] improved continuously compared to model group [21 d:(8.42 ± 0.39) points and 28 d:(8.84 ± 0.25) points],but all were lower than that in control group [(21.00 ±0.00)points,P ＜0.05].ACTH contents in model and treatment groups at 14d [(104.80±6.16) and (98.50 ± 4.07) pg/ml] and 28 d [(101.40±2.33) and (96.50± 2.28) pg/ml] were higher than those in control group [(90.40 ± 1 1.36) and (83.20 ± 5.22) pg/ml] (P ＜ 0.05).CORT contents in model and treatment groups [(44.40 ± 1.44) and (43.30 ± 1.17) ng/ml] was lower than that in control group [(48.20 ± 2.27) ng/ml] at 14 d,but were found to be elevated [(70.40 ± 1.90) and (61.40 ± 1.83) ng/ml] compared to control group [(46.40 ± 1.49) ng/ml] at 28 d (P ＜ 0.05).Meanwhile,the CORT content in treatment group was lower than that in model group (P ＜ 0.05).Changes in NE and E contents among the groups were similar with ACTH.Immunohistochemical staining suggested the amounts of GluR1 and GluR2 positive cells in treatment group lowered compared to control group (P ＜ 0.05),but increased in model group compared to control group (P ＜ 0.05).Conclusion BMSCs transplantation can improve the hindlimb motor function,contribute to reducing the secretion of stress-related hormones ACTH,CORT,NE and E,and down-regulate the expression of AMPA receptor proteins GluR1 and GluR2 in rats with spinal cord injury,suggesting a potential role in antichronic stress.

Bone Marrow Mesenchymal Stem Cells Combined with Minocycline Improve Spinal Cord Injury in A Rat Model

Bone Marrow Mesenchymal Stem Cells (bmscs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration

Bone marrow stromal cells inhibit caspase-12 expression in rats with spinal cord injury.

Bone Marrow Mesenchymal Stem Cells Decrease CHOP Expression and Neuronal Apoptosis after Spinal Cord Injury.

Thrombospondin-1 Modified Bone Marrow Mesenchymal Stem Cells (bmscs) Promote Neurite Outgrowth and Functional Recovery in Rats with Spinal Cord Injury.

Transplantation Of Bone Marrow Mesenchymal Stem Cells Inhibits Apoptosis In Injured Rat Spinal Cord

The treatment of spinal cord injury in rats using bone marrow-derived neural-like cells induced by cerebrospinal fluid

Combination of Activated Schwann Cells with Bone Mesenchymal Stem Cells: the Best Cell Strategy for Repair after Spinal Cord Injury in Rats

Neuroprotective Effect of Bone Marrow Stromal Cell Combination with Atorvastatin in Rat Model of Spinal Cord Injury.

Spinal Cord Injury in Rats Treated Using Bone Marrow Mesenchymal Stem-Cell Transplantation.

Bone Marrow Mesenchymal Stem Cells Transplantation Combined with Exercise Training Synergistically Promoted Functional Recovery After Spinal Cord Injury.

Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury

Resveratrol Enhances the Efficacy of Combined BM-MSCs Therapy for Rat Spinal Cord Injury via Modulation of the Sirt-1/NF-κB Signaling Pathway

Bone marrow mesenchymal stem cells improve spinal function of spinal cord injury in rats via TGF-β/Smads signaling pathway

Research on the effect and mechanism of the CXCR-4-overexpressing BMSCs combined with SDF-1 alpha for the cure of acute SCI in rats

Effect of TNF-α Inhibition on Bone Marrow-Derived Mesenchymal Stem Cells in Neurological Function Recovery after Spinal Cord Injury Via the Wnt Signaling Pathway in a Rat Model

RETRACTED: Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined with Erythropoietin Can Improve Acute Spinal Cord Injury

Enhanced effect of combining bone marrow mesenchymal stem cells (BMMSCs) and pulsed electromagnetic fields (PEMF) to promote recovery after spinal cord injury in mice

Vascular Endothelial Growth Factor-Transfected Bone Marrow Mesenchymal Stem Cells Improve the Recovery of Motor and Sensory Functions of Rats With Spinal Cord Injury

Bone Marrow Mesenchymal Stem Cells-Derived Extracellular Vesicle miR-208a-3p Alleviating Spinal Cord Injury via Regulating the Biological Function of Spinal Cord Neurons

Anti-chronic stress effect of bone marrow mesenchymal stem cell transplantation in rats with spinal cord injury